
Zatrocef S 1000mg/500mg Injection
Marketer
Zatropha Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Zatrocef S 1000mg/500mg Injection
Ceftazidime/Sulbactam 1000mg/500mg injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; adhere to all scheduled doses. Complete the prescribed course, regardless of symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically not impairing driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor might order blood tests and other assessments to monitor the medicine's impact.
Primary Ingredients of Zatrocef S 1000mg/500mg Injection
No information provided. Therefore, no rephrased text can be given.
Uses of Zatrocef S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Zatrocef S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Zatrocef S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Zatrocef S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Zatrocef S 1000mg/500mg Injection works:
Zatrocef S Injection (1000mg/500mg) unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam's role is to counteract bacterial resistance, thus optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Zatrocef S 1000mg/500mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Zatrocef S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
The administration of Zatrocef S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Zatrocef S 1000mg/500mg Injection could lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zatrocef S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Caution is advised when administering Zatrocef S 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Altering the Zatrocef S 1000mg/500mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Zatrocef S 1000mg/500mg Injection :
Omit a Zatrocef S 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Zatrocef S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
